These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30329068)

  • 1. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2.
    Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J
    Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of
    Suzuki H; Hosomi K; Nasu A; Kondoh M; Kunisawa J
    Front Immunol; 2018; 9():2320. PubMed ID: 30356722
    [No Abstract]   [Full Text] [Related]  

  • 3. Endotoxin-Free Stx2B-C-CPE Vaccine and Its Optimized Adjuvant Regimen for Preventing Food Poisoning.
    Hosomi K; Shimoyama A; Hinenoya A; Hatanaka N; Noguchi T; Ebina H; Tojima Y; Furuta M; Kondoh M; Kiyono H; Yamasaki S; Fukase K; Kunisawa J
    Front Biosci (Landmark Ed); 2023 Jan; 28(1):15. PubMed ID: 36722281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with BLS-Stx2B chimera totally protects dams from early pregnancy loss induced by Shiga toxin type 2 (Stx2) and confers anti-Stx2 immunity to the offspring.
    Sacerdoti F; Mejías MP; Bruballa AC; Alvarez RS; Amaral MM; Palermo MS; Ibarra C
    Vaccine; 2016 Sep; 34(39):4732-4737. PubMed ID: 27527816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.
    Lan H; Hosomi K; Kunisawa J
    Vaccine; 2019 Sep; 37(42):6232-6239. PubMed ID: 31466706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
    Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
    Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin.
    Tsuji T; Shimizu T; Sasaki K; Shimizu Y; Tsukamoto K; Arimitsu H; Ochi S; Sugiyama S; Taniguchi K; Neri P; Mori H
    Vaccine; 2008 Jan; 26(4):469-76. PubMed ID: 18093704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.
    Fujii J; Naito M; Yutsudo T; Matsumoto S; Heatherly DP; Yamada T; Kobayashi H; Yoshida S; Obrig T
    Clin Vaccine Immunol; 2012 Dec; 19(12):1932-7. PubMed ID: 23035176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
    Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
    Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
    Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
    Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxin-producing
    Montero DA; Garcia-Betancourt R; Vidal RM; Velasco J; Palacios PA; Schneider D; Vega C; Gómez L; Montecinos H; Soto-Shara R; Oñate Á; Carreño LJ
    Front Immunol; 2023; 14():1186368. PubMed ID: 37575242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2.
    Arimitsu H; Sasaki K; Iba Y; Kurosawa Y; Shimizu T; Tsuji T
    Microbiol Immunol; 2015 Feb; 59(2):71-81. PubMed ID: 25521016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
    Mietzner TA; Kokai-Kun JF; Hanna PC; McClane BA
    Infect Immun; 1992 Sep; 60(9):3947-51. PubMed ID: 1500207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative and Highly Sensitive Detection of
    Neumann T; Krüger M; Weisemann J; Mahrhold S; Stern D; Dorner MB; Feraudet-Tarisse C; Pöhlmann C; Schulz K; Messelhäußer U; Rimek D; Gessler F; Elßner T; Simon S; Rummel A; Dorner BG
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917845
    [No Abstract]   [Full Text] [Related]  

  • 19. Shiga toxin type 2 B subunit protects mice against toxin challenge when leashed and bundled by a stable pentameric coiled-coil molecule.
    Tamaki Y; Harakuni T; Arakawa T
    Vaccine; 2024 Mar; 42(7):1757-1767. PubMed ID: 38365487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS).
    Mejías MP; Hiriart Y; Lauché C; Fernández-Brando RJ; Pardo R; Bruballa A; Ramos MV; Goldbaum FA; Palermo MS; Zylberman V
    Sci Rep; 2016 Apr; 6():24913. PubMed ID: 27118524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.